There is some debate over whether this qualifies as a blue-collar job. After all, ATCs usually earn more than $100,000 per year, work in an office-type surrounding, and supervise airline pilots, who themselves earn six-figure salaries.
Good news everyone! The Patent Office has granted a patent on a cure for cancer. Last December, the Patent Office issued Patent No. 8,609,158 on a âpotent drugâ that ârebukes cancer, cancer cells, and kills cancer.â According to the patent, this drug cures a litany of other maladies.
The first commercial gene therapy, Gendicine, was approved in China in 2003 for the treatment of certain cancers. In 2011 Neovasculgen was registered in Russia as the first-in-class gene-therapy drug for treatment of peripheral artery disease, including critical limb ischemia.